AstraZeneca PLC

Tweet this page
<
2020
2021
2022
2023
2024
>
Registration as it was on 25 Mar 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

700,000€ - 799,999€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

3.45 Fte (7)

Lobbyists with EP accreditation

1

High-level Commission meetings

7

Lobbying Costs over the years

  • Info

    AstraZeneca PLC

    EU Transparency Register

    249402638316-62 First registered on 28 May 2020

    Goals / Remit

    AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

    Main EU files targeted

    Our engagement with the EU institutions focuses, among others, on the following topics:
    - Healthcare
    - Pharmaceutical policy
    - R&D
    - Trade
    - Sustainability
    - Environment
    - Public Health
    - Industrial Policy
    - Intellectual Property

    Address

    Head Office
    1 Francis Crick Avenue Cambridge Biomedical Campus
    Cambridge CB2 0AA
    UNITED KINGDOM
    EU Office
    29-33 Rue Des Deux Eglises
    Brussels 1000
    BELGIUM

    Website

  • People

    Total lobbyists declared

    7

    Employment timeLobbyists
    100%2
    75%1
    25%2
    10%2

    Lobbyists (Full time equivalent)

    3.45

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    1 accreditations were / are live (in bold) for the selected state of 22 Jun 2024

    Name Start date End Date
    Ava LLOYD 20 Mar 2024 02 Oct 2024

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    European Federation of Pharmaceutical Industries and Associations (EFPIA) - www.efpia.eu

    International Pharmaceutical Aerosol Consortium (IPAC) - www.ipacinhaler.org

    European Roundtable For Industry (ERT) - www.ert.eu

    Member organisations

    European Policy Centre https://epc.eu/en/

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    700,000€ - 799,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    NameAmount
    edelman public relations worldwide 100,000€ - 199,999€
    kreab worldwide 100,000€ - 199,999€
    flint europe 200,000€ - 299,999€
    acumen public affairs 50,000€ - 99,999€

    Intermediaries for current year

    Name
    edelman public relations worldwide
    kreab worldwide
    flint europe

    Closed year Costs

    700,000€ - 799,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    Engaging with EU policy makers and stakeholders.

    Other activities

    None declared

  • Meetings

    Meetings

    7 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    • Date 12 Apr 2021 Location Brussels
      Subject Vaccine production and delivery schedule for Q2 2021
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Maurits-Jan Prinz (Cabinet member)
    • Date 11 Apr 2021 Location Videocall
      Subject Vaccine production and deliveries
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Thierry Breton (Commissioner)
    • Date 11 Feb 2021 Location webex
      Subject vaccines - delivery schedule
      DG Health and Food Safety
      Attending
      • Sandra Gallina (Director-General)
    • Date 01 Feb 2021 Location webex
      Subject vaccines
      DG Health and Food Safety
      Attending
      • Sandra Gallina (Director-General)
    • Date 31 Jan 2021 Location Videoconference
      Subject Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Attending
      • Ursula von der Leyen (President)
      Other Lobbyists
    • Date 21 Jan 2021 Location webex
      Subject follow up vaccines
      DG Health and Food Safety
      Attending
      • Sandra Gallina (Director-General)
    • Date 11 Jan 2021 Location Skype
      Subject Follow-up over vaccines
      DG Health and Food Safety
      Attending
      • Sandra Gallina (Director-General)
Download this datacard